From professional translators, enterprises, web pages and freely available translation repositories.
hr
hr
Last Update: 2011-10-23
Usage Frequency: 3
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
hr hr
hr
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
mrt (hr)
1. 1, 2. 4
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
hr – croacia
hr – il-kroazja
Last Update: 2014-11-12
Usage Frequency: 6
Quality:
n= 1017) hr
hr
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
hr (95% ci)
hr (95% ci)
Last Update: 2011-10-23
Usage Frequency: 3
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
dosificado 1 hr
6
Last Update: 2011-10-23
Usage Frequency: 2
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
2 hr después de
sagħtejn wara
Last Update: 2012-04-11
Usage Frequency: 3
Quality:
auc0-∞ (ui × hr/ d)
(sigħat) auc0- ∞ (iu x hr/ dl)
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
aclaramiento (m/ hr/ kg)
idum biex jiġi eliminat (ml/ siegħa/ kg)
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
hr/ l) (crcl = 75 ml/ min).
hr/ l) (crcl=75 ml/ min).
Last Update: 2012-04-11
Usage Frequency: 1
Quality:
razón de riesgo (hr) (95% ci)
proporzjon ta 'periklu (hr) (95% ci)
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
reino unido telfanyl 25 microgram/ hr transdermal patch
dan il- fuljett kien approvat l- aħħar f ’ {xx/ ssss}
Last Update: 2012-04-11
Usage Frequency: 7
Quality:
ci 0,6-0,9) o mayores (hr = 0,79.
l- effett ta ’ tarceva fuq is- sopravivenza totali kienet simili f’ pazjenti b’ linja bażi tal- performance status (ecog) ta ’ 2- 3 (hr = 0. 77, ci 0. 6- 1. 0) jew 0- 1 (hr = 0. 73, 0. 6- 0. 9), rġiel (hr = 0. 76, ci 0. 6- 0. 9) jew pazjenti nisa (hr = 0. 80, ci 0. 6- 1. 1), pazjenti b’ eta ’ < 65 sena (hr = 0. 75, ci 0. 6- 0. 9) jew pazjenti ixjaħ (hr = 0. 79, ci 0. 6- 1. 0), pazjenti li ħadu kors minn qabel (hr = 0. 76, ci 0. 6- 1. 0) jew ħadu aktar minn kors wieħed minn qabel (hr = 0. 75, ci 0. 6- 1. 0), kawkasu (hr = 0. 79, ci 0. 6- 1. 0) jew pazjenti asjatiċi (hr = 0. 61, 0. 4- 1. 0), pazjenti b’ adenokarċinoma (hr = 0. 71, ci 0. 6- 0. 9) jew karċinoma squamous cell (hr = 0. 67, ci 0. 5- 0. 9), iżda mhux f’ pazjenti b’ istoloġijiet oħra (hr 1. 04, ci 0. 7- 1. 5), pazjenti b’ marda f’ stadju iv fil- ħin tad- dijanjosi (hr = 0. 92, ci 0. 7- 1. 2) jew b ’ marda < stadju iv fil - ħin tad- dijanjosi (hr = 0. 65, 0. 5- 0. 8).
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: Contains invisible HTML formatting
Warning: This alignment may be wrong.
Please delete it you feel so.
telfanyl 100 microgram/ hr transdermal patch (pending)
telfanyl 100 microgram/ hr transdermal patch (pending)
Last Update: 2011-10-23
Usage Frequency: 4
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
ci 0,4 - 1,0), pacientes con adenocarcinoma (hr = 0,71.
l- effett ta ’ tarceva fuq is- sopravivenza totali kienet simili f’ pazjenti b’ linja bażi tal- performance status (ecog) ta ’ 2- 3 (hr = 0. 77, ci 0. 6- 1. 0) jew 0- 1 (hr = 0. 73, 0. 6- 0. 9), rġiel (hr = 0. 76, ci 0. 6- 0. 9) jew pazjenti nisa (hr = 0. 80, ci 0. 6- 1. 1), pazjenti b’ eta ’ < 65 sena (hr = 0. 75, ci 0. 6- 0. 9) jew pazjenti ixjaħ (hr = 0. 79, ci 0. 6- 1. 0), pazjenti li ħadu kors minn qabel (hr = 0. 76, ci 0. 6- 1. 0) jew ħadu aktar minn kors wieħed minn qabel (hr = 0. 75, ci 0. 6- 1. 0), kawkasu (hr = 0. 79, ci 0. 6- 1. 0) jew pazjenti asjatiċi (hr = 0. 61, 0. 4- 1. 0), pazjenti b’ adenokarċinoma (hr = 0. 71, ci 0. 6- 0. 9) jew karċinoma squamous cell (hr = 0. 67, ci 0. 5- 0. 9), iżda mhux f’ pazjenti b’ istoloġijiet oħra (hr 1. 04, ci 0. 7- 1. 5), pazjenti b’ marda f’ stadju iv fil- ħin tad- dijanjosi (hr = 0. 92, ci 0. 7- 1. 2) jew b ’ marda < stadju iv fil - ħin tad- dijanjosi (hr = 0. 65, 0. 5- 0. 8).
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: Contains invisible HTML formatting
Warning: This alignment may be wrong.
Please delete it you feel so.
supervivencia (meses) mediana (m) 95% ic para la mediana hr
Żmien ta ’ sopravivenza (xhur) medjan (m) 95% ci għal medjan hr
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
javier solana, sg/hr, acoge a ban ki-moon, secretario general de las naciones unidas
is-sur javier solana, sĠ/rgħ, jilqa’ lis-sur ban ki-moon, segretarju Ġenerali tan-nazzjonijiet uniti
Last Update: 2014-02-06
Usage Frequency: 1
Quality:
ci 0,6-1,1), pacientes menores de 65 años (hr = 0,75.
l- effett ta ’ tarceva fuq is- sopravivenza totali kienet simili f’ pazjenti b’ linja bażi tal- performance status (ecog) ta ’ 2- 3 (hr = 0. 77, ci 0. 6- 1. 0) jew 0- 1 (hr = 0. 73, 0. 6- 0. 9), rġiel (hr = 0. 76, ci 0. 6- 0. 9) jew pazjenti nisa (hr = 0. 80, ci 0. 6- 1. 1), pazjenti b’ eta ’ < 65 sena (hr = 0. 75, ci 0. 6- 0. 9) jew pazjenti ixjaħ (hr = 0. 79, ci 0. 6- 1. 0), pazjenti li ħadu kors minn qabel (hr = 0. 76, ci 0. 6- 1. 0) jew ħadu aktar minn kors wieħed minn qabel (hr = 0. 75, ci 0. 6- 1. 0), kawkasu (hr = 0. 79, ci 0. 6- 1. 0) jew pazjenti asjatiċi (hr = 0. 61, 0. 4- 1. 0), pazjenti b’ adenokarċinoma (hr = 0. 71, ci 0. 6- 0. 9) jew karċinoma squamous cell (hr = 0. 67, ci 0. 5- 0. 9), iżda mhux f’ pazjenti b’ istoloġijiet oħra (hr 1. 04, ci 0. 7- 1. 5), pazjenti b’ marda f’ stadju iv fil- ħin tad- dijanjosi (hr = 0. 92, ci 0. 7- 1. 2) jew b ’ marda < stadju iv fil - ħin tad- dijanjosi (hr = 0. 65, 0. 5- 0. 8).
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: Contains invisible HTML formatting
Warning: This alignment may be wrong.
Please delete it you feel so.
↑ 41% auc de raltegravir ↑ 77% c12 hr de raltegravir ↑ 24% cmáx de raltegravir
raltegravir cmax ↑24%
Last Update: 2011-10-23
Usage Frequency: 4
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.